Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
Part of paid clinical trials in Anniston, Alabama.
- Sponsor
- Novartis Pharmaceuticals
- Study ID
- NCT05624749
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- ianalumab — DRUGianalumab s.c. monthly
- placebo — DRUGplacebo s.c. monthly
Study Details
The trial will evaluate efficacy, safety and tolerability of ianalumab compared to placebo, given as monthly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).
Key Dates
- Start date
- Apr 21, 2023
- Status verified
- Jun 2026
- Primary completion
- Apr 12, 2027
- Completion
- Apr 9, 2029
Study Design
- Enrollment
- 288 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ianalumab s.c. monthlyianalumab s.c. monthly
- Placebo Comparator: placebo s.c. monthlyplacebo s.c. monthly
Primary Outcome Measure
Proportion of participants achieving Systemic Lupus Erythematosus Responder Index -4 (SRI-4) [ Time Frame: Week 60 ]
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Pinnacle Research Group LLC | Anniston | Alabama | 36207-5710 | - |
| Advanced Medical Research | La Palma | California | 90623 | - |
| University of California LA | Los Angeles | California | 90095 | - |
| Homestead Assoc In Research Inc | Homestead | Florida | 33033 | - |
| IRIS Research and Development | Plantation | Florida | 33324 | - |
| Emory University | Atlanta | Georgia | 30307 | - |
| Willow Rheumatology Wellness | Willowbrook | Illinois | 60527 | - |
| Bluegrass Community Research Inc | Lexington | Kentucky | 40504 | - |
| Accurate Clinical Research | Lake Charles | Louisiana | 70601 | - |
| UMC New Orleans | New Orleans | Louisiana | 70112 | - |
| University Of Maryland | Baltimore | Maryland | 21201 | - |
| Ahmed Arif Medical Research Center | Grand Blanc | Michigan | 48439 | - |
| Washington Univ School Of Medicine | St Louis | Missouri | 63110 | - |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | - |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | - |
| Novel Research LLC | Bellaire | Texas | 77401 | - |
Find similar trials in Anniston, AL
By condition
By specialty
Related Studies
- Study of Systemic Lupus ErythematosusRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland
- Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)Recruiting · Hospital for Special Surgery, New York · Chicago, Illinois
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas